KEY POINTS
  • JPMorgan's small and midcap team is taking aim at stocks which are down more than 30% from pre-Covid levels, but have "solid balance sheets, near trough valuations, in businesses that are not structurally damaged."

With one in every five small and midcap stocks still down more than 30% since the beginning of the coronavirus crisis, it has "never been easier to make money," according to JPMorgan's Global Head of Small and Midcap Equity Strategy Eduardo Lecubarri.

His comments come as economic data mostly points towards a continued recovery for the global economy in July, while governments and central banks have deployed unprecedented levels of monetary stimulus to keep markets functioning.